Drug–Drug Interactions of Infectious Disease Treatments in Low‐Income Countries: A Neglected Topic?

Despite recent advances in recognizing and reducing the risk of drug–drug interactions (DDIs) in developed countries, there are still significant challenges in managing DDIs in low‐income countries (LICs) worldwide. In the treatment of major infectious diseases in these regions, multiple factors con...

Ausführliche Beschreibung